Prognosis and acute complications at the first onset of idiopathic nephrotic syndrome in children: a nationwide survey in Japan (JP-SHINE study)

Mai Sato(Kyoto University), Kaori Kikunaga(Tokyo Metropolitan Children's Medical Center), Riku Hamada, Yuko Hamasaki(Toho University), Koichi Nakanishi(University of the Ryukyus), Kazumoto Iijima(Kobe Children's Hospital), Yoshimitsu Gotoh(Japanese Red Cross Nagoya Daini Hospital), Hitoshi Nakazato(Kumamoto University), Shuichi Ito(Yokohama City University), Chikako Terano(National Center For Child Health and Development), Shingo Ishimori(Kobe University), Kenji Ishikura(Kitasato University), Masataka Honda(Rikkyo University), Takashi Ando(Japan Clinical Cancer Research Organization), Norishige Yoshikawa(Takatsuki General Hospital), Yoshinori Araki(Ulsan College), Takeshi Matsuyama
Nephrology Dialysis Transplantation
August 11, 2019
10.1093/ndt/gfz185
Cited by 34

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135